The role of immunological factors in the development of abnormal uterine bleeding in women of reproductive age with extragenital disorders
DOI:
https://doi.org/10.15587/2519-4798.2022.262184Keywords:
abnormal uterine bleeding, immune system, antiplatelet autoantibodies, phagocytic reactions, humoral sensitizationAbstract
The aim of the study was to assess the role of immunological factors in the development of abnormal uterine bleeding in women of reproductive age with extragenital disorders.
Materials and methods. The study involved 100 women with abnormal uterine bleeding and accompanying extragenital disorders (main group) and 50 somatically healthy women (control group). Autoimmune antibodies to platelets, phagocytic activity of neutrophil granulocytes, concentration of circulating immune complexes (CICs), total level of membranotropic cytotoxic factors, content of CD4+T-helper subpopulations and cytotoxic CD8+T-killer lymphocytes were evaluated as immunological markers.
Results of the study. The study showed that thrombocytopenia, caused by the presence of autoimmune antibodies to their own platelets, can be one of the pathogenic factors of bleeding in women with AUB. In 41 % of women with AUB, phagocytic reactions were found to be intense, which was expressed by an increase in chemotaxis and adhesion functions, and in 46 % of women by an increase in the absorption capacity of phagocytes. In the main group, 48 % of the examined women had insufficient phagocyte enzymatic activity, which was evidenced by a decrease in the index of completion of phagocytosis. In 79 % of women of the main group, violations of the formation and elimination of circulating immune complexes were detected. The formation of low-molecular-weight CICs in 82 % of women of this cohort contributed to the induction of autoimmune reactions. The total content of membranotropic cytotoxic factors, which was evaluated according to the lymphocytotoxic test, exceeded the reference values in 88 % of women of the main group. In the main group, the average content of CD4+ T-helpers was 23 % lower, and the content of suppressor CD8+ T-lymphocytes was twice as low compared to the control group, resulting in a significant increase in the immunoregulatory index by 30 %.
Conclusion. The women of the main group with abnormal uterine bleeding were found to have a violation of the functional activity of cellular factors of innate immunity, accompanied by changes in the absorption and digestive capacity of phagocytic cells. Assessment of secondary adaptive reactions showed induction of humoral sensitization and formation of autoimmune reactions (presence of antiplatelet autoantibodies, increase in CICs and LCT, decrease in the subpopulation of CD8+-suppressor T-lymphocytes). The detected violations indicate the pathogenic role of immunological reactions in women with abnormal uterine bleeding
References
- ACOG committee opinion no. 557: Management of acute abnormal uterine bleeding in nonpregnant reproductive-aged women (2013). Obstetrics and gynecology, 121 (4), 891–896. doi: http://doi.org/10.1097/01.aog.0000428646.67925.9a
- Kazemijaliseh, H., Ramezani Tehrani, F., Behboudi-Gandevani, S., Khalili, D., Hosseinpanah, F., Azizi, F. (2017). A Population-Based Study of the Prevalence of Abnormal Uterine Bleeding and its Related Factors among Iranian Reproductive-Age Women: An Updated Data. Archives of Iranian medicine, 20 (9), 558–563.
- Marie, K., Cyrille, N., Etienne, B., Pascal, F. (2020). Epidemiological Profile of Abnormal Uterine Bleeding at the Gyneco-Obstetric and Pediatric Hospital of Yaounde. Open Journal of Obstetrics and Gynecology, 10, 237–242. doi: http://doi.org/10.4236/ojog.2020.1020020
- Whitaker, L., Critchley, H. O. (2016). Abnormal uterine bleeding. Best practice & research. Clinical obstetrics & gynaecology, 34, 54–65. doi: http://doi.org/10.1016/j.bpobgyn.2015.11.012
- Singh, S., Best, C., Dunn, S., Leyland, N., Wolfman, W. L. et. al. (2013). Abnormal uterine bleeding in pre-menopausal women. Journal of obstetrics and gynaecology Canada, 35 (5), 473–475. doi: http://doi.org/10.1016/s1701-2163(15)30939-7
- Iniyaval, R., Jayanthi, B., Lavanya, S., Renuka K. (2021). A Study to Assess the Prevalence and Contributing Factors of Abnormal Uterine Bleeding among Women Admitted in MGMCRI from January to December 2019. Pondicherry Journal of Nursing, 14 (1), 8–10. doi: http://doi.org/10.5005/jp-journals-10084-12173
- de Léotoing, L., Chaize, G., Fernandes, J., Toth, D., Descamps, P., Dubernard, G. et. al. (2019). The surgical treatment of idiopathic abnormal uterine bleeding: An analysis of 88 000 patients from the French exhaustive national hospital discharge database from 2009 to 2015. PloS one, 14 (6), e0217579. doi: http://doi.org/10.1371/journal.pone.0217579
- Schoep, M. E., Adang, E., Maas, J., De Bie, B., Aarts, J., Nieboer, T. E. (2019). Productivity loss due to menstruation-related symptoms: a nationwide cross-sectional survey among 32 748 women. BMJ open, 9 (6), e026186. doi: http://doi.org/10.1136/bmjopen-2018-026186
- Bennett, A., Thavorn, K., Arendas, K., Coyle, D., Singh, S. S. (2020). Outpatient uterine assessment and treatment unit in patients with abnormal uterine bleeding: an economic modelling study. CMAJ open, 8 (4), E810–E818. doi: http://doi.org/10.9778/cmajo.20190170
- Hale, K. (2018). Abnormal Uterine Bleeding: A Review. US Pharm, 43 (9), HS2–HS9
- Alzahrani, F., Hassan, F. (2019). Modulation of Platelet Functions Assessment during Menstruation and Ovulatory Phases. Journal of medicine and life, 12 (3), 296–300. doi: http://doi.org/10.25122/jml-2019-0005
- Dickerson, K. E., Menon, N. M., Zia, A. (2018). Abnormal Uterine Bleeding in Young Women with Blood Disorders. Pediatric clinics of North America, 65 (3), 543–560. doi: http://doi.org/10.1016/j.pcl.2018.02.008
- Kristina, M., Lattimore, S., McDavitt, С., Khader, A., Boehnlein, C., Baker-Groberg, S. et. al. (2016). Haley Identification of Qualitative Platelet Disorders in Adolescent Women with Heavy Menstrual Bleeding. Blood, 22 (128), 4922. doi: http://doi.org/10.1182/blood.v128.22.4922.4922
- Amesse, L. S., Pfaff-Amesse, T., Gunning, W. T., Duffy, N., French, J. A. (2013). Clinical and laboratory characteristics of adolescents with platelet function disorders and heavy menstrual bleeding. Experimental hematology & oncology, 2 (1), 3. doi: http://doi.org/10.1186/2162-3619-2-3
- Critchley, H., Maybin, J. A., Armstrong, G. M., Williams, A. (2020). Physiology of the Endometrium and Regulation of Menstruation. Physiological reviews, 100 (3), 1149–1179. doi: http://doi.org/10.1152/physrev.00031.2019
- Alaqzam, T. S., Stanley, A. C., Simpson, P. M., Flood, V. H., Menon, S. (2018). Treatment Modalities in Adolescents Who Present with Heavy Menstrual Bleeding. Journal of pediatric and adolescent gynecology, 31 (5), 451–458. doi: http://doi.org/10.1016/j.jpag.2018.02.130
- Schatz, F., Guzeloglu-Kayisli, O., Arlier, S., Kayisli, U. A., Lockwood, C. J. (2016). The role of decidual cells in uterine hemostasis, menstruation, inflammation, adverse pregnancy outcomes and abnormal uterine bleeding. Human reproduction update, 22 (4), 497–515. doi: http://doi.org/10.1093/humupd/dmw004
- Maybin, J. A., Murray, A. A., Saunders, P., Hirani, N., Carmeliet, P., Critchley, H. (2018). Hypoxia and hypoxia inducible factor-1α are required for normal endometrial repair during menstruation. Nature communications, 9 (1), 295. doi: http://doi.org/10.1038/s41467-017-02375-6
- Hapangama, D. K., Bulmer, J. N. (2016). Pathophysiology of heavy menstrual bleeding. Women's health, 12 (1), 3–13. doi: http://doi.org/10.2217/whe.15.81
- Critchley, H., Babayev, E., Bulun, S. E., Clark, S., Garcia-Grau, I., Gregersen, P. K. et. al. (2020). Menstruation: science and society. American journal of obstetrics and gynecology, 223 (5), 624–664. doi: http://doi.org/10.1016/j.ajog.2020.06.004
- Lee, S. K., Kim, C. J., Kim, D. J., Kang, J. H. (2015). Immune cells in the female reproductive tract. Immune network, 15 (1), 16–26. doi: http://doi.org/10.4110/in.2015.15.1.16
- Maybin, J. A., Critchley, H. O. (2015). Menstrual physiology: implications for endometrial pathology and beyond. Human reproduction update, 21 (6), 748–761. doi: http://doi.org/10.1093/humupd/dmv038
- Jabbour, H. N., Sales, K. J., Catalano, R. D., Norman, J. E. (2009). Inflammatory pathways in female reproductive health and disease. Reproduction, 138 (6), 903–919. doi: http://doi.org/10.1530/rep-09-0247
- Lysenko, O. N., Strizhova, N. V., Kholodova, Z. (2003). Parameters of cellular immunity in perimenopausal patients with glandular and adenomatous endometrial hyperplasia. Bulletin of experimental biology and medicine, 135 (1), 77–80. doi: http://doi.org/10.1023/a:1023410332246
- Fraser, I. S., Mansour, D., Breymann, C., Hoffman, C., Mezzacasa, A., Petraglia, F. (2015). Prevalence of heavy menstrual bleeding and experiences of affected women in a European patient survey. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 128 (3), 196–200. doi: http://doi.org/10.1016/j.ijgo.2014.09.027
- Rodeghiero, F., Marranconi, E. (2020). Management of immune thrombocytopenia in women: current standards and special considerations. Expert Review of Hematology, 13 (2), 175–185. doi: http://doi.org/10.1080/17474086.2020.1711729
- van Dijk, W., Punt, M. C., van Galen, K., van Leeuwen, J., Lely, A. T., Schutgens, R. (2022). Menstrual problems in chronic immune thrombocytopenia: A monthly challenge – a cohort study and review. British journal of haematology, 10. doi: https://doi.org/10.1111/bjh.18291
- Cooper, N., Kruse, A., Kruse, C., Watson, S., Bussel, J. B. (2021). Immune thrombocytopenia (ITP) World Impact Survey (iWISh): Patient and physician perceptions of diagnosis, signs and symptoms, and treatment. American journal of hematology, 96 (2), 188–198. doi: http://doi.org/10.1002/ajh.26045
- Burbano, C., Villar-Vesga, J., Vásquez, G., Muñoz-Vahos, C., Rojas, M., Castaño, D. (2019). Proinflammatory Differentiation of Macrophages Through Microparticles That Form Immune Complexes Leads to T- and B-Cell Activation in Systemic Autoimmune Diseases. Frontiers in immunology, 10, 2058. doi: http://doi.org/10.3389/fimmu.2019.02058
- McInnes, I. B., Schett, G. (2011). The pathogenesis of rheumatoid arthriis. The New England journal of medicine, 365 (23), 2205–2219. doi: http://doi.org/10.1056/nejmra1004965
- Burbano, C., Villar-Vesga, J., Orejuela, J., Muñoz, C., Vanegas, A., Vásquez, G., Rojas, M., Castaño, D. (2018). Potential Involvement of Platelet-Derived Microparticles and Microparticles Forming Immune Complexes during Monocyte Activation in Patients with Systemic Lupus Erythematosus. Frontiers in immunology, 9, 322. doi: http://doi.org/10.3389/fimmu.2018.00322
- Burbano, C., Rojas, M., Vásquez, G., Castaño, D. (2015). Microparticles That Form Immune Complexes as Modulatory Structures in Autoimmune Responses. Mediators of inflammation, 2015. doi: http://doi.org/10.1155/2015/267590
- Mayadas, T. N., Tsokos, G. C., Tsuboi, N. (2009). Mechanisms of immune complex-mediated neutrophil recruitment and tissue injury. Circulation, 120 (20), 2012–2024. doi: http://doi.org/10.1161/circulationaha.108.771170
- Thurman, J. M., Yapa, R. (2019). Complement Therapeutics in Autoimmune Disease. Frontiers in immunology, 10, 672. doi: http://doi.org/10.3389/fimmu.2019.00672
- Kaul, A., Gordon, C., Crow, M. K., Touma, Z., Urowitz, M. B., Ruiz-Irastorza, G. et. al. (2016). Systemic lupus erythematosus. Nature Reviews Disease Primers, 2 (1). doi: http://doi.org/10.1038/nrdp.2016.39
- Yan, M., Marsters, S. A., Grewal, I. S., Wang, H., Ashkenazi, A., Dixit, V. M. (2000). Identification of a receptor for BLyS demonstrates a crucial role in humoral immunity. Nature immunology, 1 (1), 37–41. doi: http://doi.org/10.1038/76889
- Lai, Z. Z., Ruan, L. Y., Wang, Y., Yang, H. L., Shi, J. W., Wu, J. N. et. al. (2020). Changes in subsets of immunocytes in endometrial hyperplasia. American journal of reproductive immunology, 84 (4), e13295. doi: http://doi.org/10.1111/aji.13295
- Witkiewicz, A. K., McConnell, T., Potoczek, M., Emmons, R. V., Kurman, R. J. (2010). Increased natural killer cells and decreased regulatory T cells are seen in complex atypical endometrial hyperplasia and well-differentiated carcinoma treated with progestins. Human pathology, 41 (1), 26–32. doi: http://doi.org/10.1016/j.humpath.2009.06.012
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Iryna Tuchkina , Roman Blagoveshchensky
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our journal abides by the Creative Commons CC BY copyright rights and permissions for open access journals.
Authors, who are published in this journal, agree to the following conditions:
1. The authors reserve the right to authorship of the work and pass the first publication right of this work to the journal under the terms of a Creative Commons CC BY, which allows others to freely distribute the published research with the obligatory reference to the authors of the original work and the first publication of the work in this journal.
2. The authors have the right to conclude separate supplement agreements that relate to non-exclusive work distribution in the form in which it has been published by the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.